SEC Form 4 · accession 0001140361-18-028738
CHEMBIO DIAGNOSTICS, INC. · CEMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Javan Esfandiari
Officer — Chief Science/Tech Officer
Period of report
Jun 13, 2018
Accepted (ET)
Jun 15, 2018 · 12:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001092662
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 13, 2018 | M | 20,000 | $5.64 | A | 111,258 | D | |
| Common StockF1 | Jun 13, 2018 | F | 11,345 | — | D | 99,913 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase common stock | $5.64 | Jun 13, 2018 | M | 20,000 | D | Mar 11, 2018 | Mar 11, 2021 | Common Stock | 20,000 | 0 | D |
Explanation of responses
- F1The reporting person did not sell any shares of common stock. Rather, the reporting person exercised options to acquire 18,712 shares of common stock by submitting and relinquishing to the issuer (i) options to purchase an additional 1,288 shares of common stock and (ii) 10,057 shares of common stock. These additional options to purchase 1,288 shares of common stock and the 10,057 shares of common stock constituted the entire exercise price, using the 10-day volume weighted average trading price ended June 12, 2018 of $9.9432. As a result of these transactions, the reporting person increased his common stock ownership by a net addition of 8,655 shares.